LNSR — LENSAR Inc
NASDAQ · Healthcare · Medical Devices
$8.46
+$0.07 (+0.83%)
LENSAR Inc (LNSR) is a medical devices company listed on NASDAQ. It is led by Nicholas T. Curtis, based in 2800 Discovery Drive, Orlando, FL, United States, 32826, with about 140 employees. LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Latest reported LNSR revenue for 2025-09-30 was $14.3M. Net income was -$32.8M. Revenue was up 2.7% from 2025-06-30 to 2025-09-30. LNSR currently screens at market cap $156.7M.
Use this LNSR page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the LNSR quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the LNSR SEC filings page. Lician reads the product cache first so this HTML stays unique to LENSAR Inc even when a live quote feed is slow.
About LENSAR Inc
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
LNSR Key Statistics
Market Cap
$156.67M
Volume
71,518
Previous Close
$8.94
Day Range
$8.54 – $8.94
EPS
-$2.73
Revenue
$53.49M
Net Income
-$31.40M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
+26.9%
Profit Margin
-58.7%
Employees
140
LNSR Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|
| Revenue | $53.49M | $42.16M | $35.36M | $34.46M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 | $0.00 | $0.00 |
| Net Income | -$31.40M | -$14.38M | -$19.91M | -$19.60M |
| EPS (Diluted) | -$2.73 | -$1.31 | -$1.96 | -$2.09 |
Total Assets
$66.30M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$16.26M
Operating Cash Flow
-$2.27M
Free Cash Flow
$0.00
LENSAR Inc Company Information
- President, CEO & Director
- Nicholas T. Curtis
- Headquarters
- 2800 Discovery Drive, Orlando, FL, United States, 32826
- Website
- www.lensar.com
- Phone
- 888 536 7271
- IPO / Founded
- 2020-10-02
- Sector
- Healthcare
- Industry
- Medical Devices